Navigation Links
Warning of Statin Drug Lipitor’s Risk of Type 2 Diabetes Came Too Late Say Patients Filing Lipitor Lawsuits
Date:9/18/2013

Los Angeles, CA (PRWEB) September 18, 2013

Some patients who have taken the statin drug Lipitor are reporting that they developed type 2 diabetes after taking the cholesterol-lowering drug despite having no known risk factors. High potency statin medications like Lipitor have been shown in some studies to increase a patient's risk of developing type 2 diabetes, a finding that many Lipitor patients say should have prompted the manufacturer of Lipitor to sufficiently warn patients of the drug’s type 2 diabetes risk before they began taking Lipitor.("Risk of Incident Diabetes Among Patients Treated with Statins: Population Based Study," May, 23, 2013, http://www.bmj.com/content/346/bmj.f2610) (In Re: Lipitor Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 2459, JPMDL)

Manufactured by Pfizer, Lipitor's side effects started to come into focus when patients who had little risk of developing type 2 diabetes began to report that they developed type 2 diabetes while taking the drug. (In Re: Lipitor Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 2459, JPMDL)

Responding to the allegations and recent studies, the Food and Drug Administration (FDA) has started to require that manufacturers of statin drugs list the associated blood sugar level risk on their warning levels. However, many patients allegedly injured by the statin claim in the Lipitor lawsuits that this warning did not come soon enough. (FDA Expands Advice on Statins Risks, February 27, 2012, http://www.fda.gov/forconsumers/consumerupdates/ucm293330.htm)

“When a medical drug or device has an associated risk or side effect, patients need to know,” said Laura Baughman, attorney at Baron and Budd. “The fact that Pfizer may not have sufficiently warn their patients of the type 2 diabetes risk associated with their very popular drug, Lipitor, is troubling."

To learn more about the associated risks of taking Lipitor, please visit http://baronandbudd.com/areas-of-practice/pharmaceuticals/lipitor-lawsuit/

To learn more about Baron and Budd’s handling of the Lipitor lawsuit or for a free consultation, please call 1.866.472.9108 or visit the firm’s website at http://baronandbudd.com.

About Baron & Budd, P.C.

With a history of over 35 years “Protecting What’s Right” for individuals, communities, and governmental entities, Baron and Budd is a well-established law firm devoted to making a positive difference. With offices in Dallas, Austin, Los Angeles and Baton Rouge, Baron and Budd is able to take on complicated and expensive cases within the realms of dangerous drugs and medical devices, asbestos-related illnesses, consumer fraud, water contamination, the Gulf oil spill and fraudulent financial practices.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11133969.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. GranuFlo Lawsuit News: Bernstein Liebhard LLP Comments on Fresenius FDA Warning Letter, as GranuFlo Recall Claims Mount
2. Injury Law Firm Comments on the FDA Consumer Update Warning about Tylenol Side Effects like SJS
3. Warning Labels Update Survives Dismissal in Fosamax Multidistrict Litigation: Now, AttorneyOne Can Provide Advice
4. Mental Health Watchdog Launches Psychiatric Drug Side Effects Database—Search All Drug Regulatory Agency Warnings, Studies & Adverse Reactions Reports
5. Injury Law Firm Releases New Informational Graphic Warning that Lead Poisoning is Still a Serious Risk in the United States
6. Zithromax Arrhythmia and Sudden Death Cases Allegations Update: Resource4thePeople Reports FDA Issued Warning Letter to Manufacturer over False and Misleading Information
7. AED.com Issues Warning to Consumers Concerning AED Scams
8. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Release of FDA Warning Letter to Intuitive Surgical
9. Vulcan Termite and Pest Control, Inc. Warning: Tiger Mosquito Invasion
10. Da Vinci Robot Lawsuits Continue as Alonso Krangle LLP Comments on Revelations in Intuitive Surgical Inc.’s FDA Warning Letter
11. Da Vinci Robot Lawsuit Lawyers at Wright & Schulte LLC Comment on FDA Warning Letter Received by Intuitive Surgical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 30, 2016 , ... World Patent Marketing ... Up Springboard, an automotive invention that improves the storage features of a pick ... billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Over ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... , announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula ... brain and mood optimization products to the store is just one more way ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House announced ... loans, more information about their loan terms and accounts, and more protections for ... including federal and private loans, has reached $1.3 trillion, with 43 million Americans ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton ... $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan Competition —as ... People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ making them ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering the many ... learn more about the options currently available to them and which ones might work ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... Oasmia Pharmaceutical AB (NASDAQ: ... new generation of drugs within human and veterinary ... Paclical/Apealea in the Phase III study that included ... cancer. These preliminary results showed non-inferiority between the ... versus Taxol in combination with carboplatin. In fact, ...
(Date:4/27/2016)... At the Sachs CEO forum ... Phase 2 clinical study of its lead drug candidate, ... implantation (CI) surgery. This large, placebo-controlled, double-blind, phase 2 ... and France . STR001 ... time of surgery. "Despite advances in cochlear implant technology, ...
(Date:4/26/2016)... April 26, 2016 US demand for ... expand 4.9 percent annually to $27.6 billion in ... facilities to decrease rates of healthcare-associated infections (HAIs) ... equipment, and services.  Although declining, the overall rate ... targeted levels set by the CDC.  Recent statistics ...
Breaking Medicine Technology: